The development of a new vaccine is a complex venture. Biotech and pharmaceutical companies are increasingly choosing to outsource their manufacturing efforts, as partnering with the right CMO can streamline this process. Since 2011, total global spending on contract manufacturing reached $31.9 billion according to a 2012 industry report entitled, “The CMO Market Outlook to 2017.” The growth trend of the past two decades is expected to continue for the next five years.
In this eBook you will find out how a vaccine developer would go about choosing their CMO partner looking at elements such as:
- Financial stability
- Company profile
- Cost Competitiveness
Then you will see VaccineNation’s Top 10 CMOs. Did your company make the list? What do you think of our top 10?
Many of the issues about will be talked about at the World Vaccine Congress Washington 2015 – don’t miss your chance to join over 200 people already confirmed to attend.